Nikhil Nayak has over two decades of relevant healthcare experience in all aspects of global commercialization, including corporate strategy, life cycle product management, business development, global marketing & sales, finance & digital strategies.
Over the course of his career at Forest Laboratories Inc. (now Allergan), Nikhil held a variety of positions of increasing responsibility in sales, marketing, and business development. In his final role at Forest, Nikhil served as Executive Director of Global Marketing & Commercialization, where he steered the successful approvals and launches of several products in Canada, Europe, and Latin America. He was the head of the Namenda franchise, accelerating growth to “Blockbuster Status” for this Alzheimer’s drug while overseeing future development programs. He was also instrumental in the successful launches of Bystolic, and blockbuster antidepressants Celexa and Lexapro, for which he was recognized as part of Medical Marketing & Media’s 2003 “Brand Team of the Year“.
Nikhil received his Bachelor’s degree in Biology from Washington University in St. Louis, and his Master’s in Business Administration from New York University, Stern School of Business.